Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bilateral Erector Spinae Blocks for Post-Sternotomy Pain
NCT04567407Phase 4Completed
- Sponsor
- Boston Children's Hospital
- Start
- Sep 2020
- Primary completion
- Jan 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ropivacaine in postoperative pain, sponsored by Boston Children's Hospital. Primary endpoints: Analgesic Requirement at 24 hours postoperatively, Analgesic Requirement at 48 hours postoperatively and 1 more. Started Sep 2020; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04567407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04567407.